CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 106 enrolled
Drug / intervention
PENG + LFC Block +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05710107
NCT05710107N/ACompleted

The Impact or Quadratum Lumborum (QL) Block Versus Pericapsular Nerve Group (PENG) With Lateral Femoral Cutaneous (LFC) Nerve Blocks for Analgesia After Hip Arthroplasty: a Prospective, Randomized Clinical Trial

Medical University of South Carolina·interventional·Posted Feb 2, 2023·Updated Dec 20, 2024

In Brief

A clinical study evaluating PENG + LFC Block and QL Block for Block and 2 related conditions. Completed, enrolled 106 participants across 1 site.

Detailed Summary

This study will consist of patients 18 years and older who are undergoing elective hip replacement with planned same day discharge. The patients will be randomized to receive a PENG+LFC or QL block prior to undergoing the surgery to help with postoperative pain control. The primary goal will be assessing postoperative opioid use during the first 72 hours after surgery. Secondary outcomes will include postoperative pain scores from, 0-72 hours. Additional outcomes consist of time to first ambulation, functional and mobility outcomes, PACU duration, patient satisfaction and opioid related side effects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedFeb 2, 2023
Enrollment StartFeb 7, 2023
Primary CompletionNov 12, 2023
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 3.4 years ago

Interventions

PENG + LFC Blockother

Subjects assigned to this group will receive PENG + LFC Block

QL Blockother

Subjects randomized to this group will receive a QL Block